Search - tctmd.com

Displaying 161 - 176 of 176

Sort: Relevancy | Date

News Daily News

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Michael O'Riordan

September 16, 2016

News Conference News ESC 2016

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Michael O'Riordan

August 30, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space

Michael O'Riordan

August 01, 2016

News Daily News

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

L.A. McKeown

July 28, 2016

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

After Study Suggests Harm With Too-Low Sodium Intake, the American Heart Association Rebukes

Todd Neale

May 24, 2016

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Todd Neale

August 20, 2014

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Jason Kahn

February 02, 2011

Advertisement

Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

After Study Suggests Harm With Too-Low Sodium Intake, the American Heart Association Rebukes

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Symic Biomedical Selects Vascular Clinical Candidate

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content